nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA1—coronary artery disease	0.267	0.608	CbGaD
Mefloquine—ADORA1—coronary artery disease	0.172	0.392	CbGaD
Mefloquine—BCHE—Perindopril—coronary artery disease	0.0404	0.13	CbGbCtD
Mefloquine—BCHE—Ramipril—coronary artery disease	0.0335	0.107	CbGbCtD
Mefloquine—ABCB1—Ticagrelor—coronary artery disease	0.0166	0.0533	CbGbCtD
Mefloquine—ABCB1—Perindopril—coronary artery disease	0.0103	0.0329	CbGbCtD
Mefloquine—ABCB1—Clopidogrel—coronary artery disease	0.0103	0.0329	CbGbCtD
Mefloquine—CYP3A4—Ticagrelor—coronary artery disease	0.00994	0.0319	CbGbCtD
Mefloquine—ABCB1—Pitavastatin—coronary artery disease	0.00896	0.0288	CbGbCtD
Mefloquine—ABCB1—Telmisartan—coronary artery disease	0.00896	0.0288	CbGbCtD
Mefloquine—CYP3A4—Fenofibrate—coronary artery disease	0.00886	0.0285	CbGbCtD
Mefloquine—ABCB1—Enalapril—coronary artery disease	0.0085	0.0273	CbGbCtD
Mefloquine—ABCB1—Lisinopril—coronary artery disease	0.0085	0.0273	CbGbCtD
Mefloquine—CYP2D6—Niacin—coronary artery disease	0.00732	0.0235	CbGbCtD
Mefloquine—ABCB1—Timolol—coronary artery disease	0.00722	0.0232	CbGbCtD
Mefloquine—CYP3A4—Gemfibrozil—coronary artery disease	0.00709	0.0228	CbGbCtD
Mefloquine—CYP2D6—Timolol—coronary artery disease	0.00681	0.0219	CbGbCtD
Mefloquine—ABCB1—Ezetimibe—coronary artery disease	0.00661	0.0212	CbGbCtD
Mefloquine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00644	0.0207	CbGbCtD
Mefloquine—ABCB1—Captopril—coronary artery disease	0.00636	0.0204	CbGbCtD
Mefloquine—CYP3A4—Clopidogrel—coronary artery disease	0.00614	0.0197	CbGbCtD
Mefloquine—ABCB1—Simvastatin—coronary artery disease	0.00614	0.0197	CbGbCtD
Mefloquine—ABCB1—Lovastatin—coronary artery disease	0.00601	0.0193	CbGbCtD
Mefloquine—ABCB1—Pravastatin—coronary artery disease	0.00601	0.0193	CbGbCtD
Mefloquine—CYP2D6—Captopril—coronary artery disease	0.00599	0.0192	CbGbCtD
Mefloquine—CYP2D6—Simvastatin—coronary artery disease	0.00579	0.0186	CbGbCtD
Mefloquine—CYP3A4—Eplerenone—coronary artery disease	0.00571	0.0183	CbGbCtD
Mefloquine—CYP2D6—Lovastatin—coronary artery disease	0.00566	0.0182	CbGbCtD
Mefloquine—CYP2D6—Pravastatin—coronary artery disease	0.00566	0.0182	CbGbCtD
Mefloquine—ABCB1—Atorvastatin—coronary artery disease	0.00548	0.0176	CbGbCtD
Mefloquine—CYP2D6—Atorvastatin—coronary artery disease	0.00516	0.0166	CbGbCtD
Mefloquine—CYP3A4—Enalapril—coronary artery disease	0.00509	0.0163	CbGbCtD
Mefloquine—ABCB1—Losartan—coronary artery disease	0.00501	0.0161	CbGbCtD
Mefloquine—CYP3A4—Ezetimibe—coronary artery disease	0.00396	0.0127	CbGbCtD
Mefloquine—CYP3A4—Rosuvastatin—coronary artery disease	0.00396	0.0127	CbGbCtD
Mefloquine—CYP3A4—Simvastatin—coronary artery disease	0.00368	0.0118	CbGbCtD
Mefloquine—CYP3A4—Lovastatin—coronary artery disease	0.0036	0.0116	CbGbCtD
Mefloquine—CYP3A4—Pravastatin—coronary artery disease	0.0036	0.0116	CbGbCtD
Mefloquine—HBA2—artery—coronary artery disease	0.00344	0.173	CbGeAlD
Mefloquine—CYP3A4—Atorvastatin—coronary artery disease	0.00328	0.0105	CbGbCtD
Mefloquine—CYP3A4—Losartan—coronary artery disease	0.003	0.00963	CbGbCtD
Mefloquine—HBA2—endothelium—coronary artery disease	0.00291	0.146	CbGeAlD
Mefloquine—HBA1—heart—coronary artery disease	0.00138	0.0694	CbGeAlD
Mefloquine—HBA1—cardiovascular system—coronary artery disease	0.0013	0.0655	CbGeAlD
Mefloquine—HBA2—heart—coronary artery disease	0.00127	0.0637	CbGeAlD
Mefloquine—HBA2—cardiovascular system—coronary artery disease	0.0012	0.0601	CbGeAlD
Mefloquine—HBA1—blood—coronary artery disease	0.00103	0.0518	CbGeAlD
Mefloquine—HBA2—blood—coronary artery disease	0.000945	0.0475	CbGeAlD
Mefloquine—ADORA1—myocardium—coronary artery disease	0.000816	0.041	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—coronary artery disease	0.000622	0.0313	CbGeAlD
Mefloquine—ADORA1—heart—coronary artery disease	0.000569	0.0286	CbGeAlD
Mefloquine—ACHE—heart—coronary artery disease	0.000566	0.0285	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—coronary artery disease	0.000537	0.027	CbGeAlD
Mefloquine—ADORA2A—blood—coronary artery disease	0.000492	0.0247	CbGeAlD
Mefloquine—ADORA1—cardiac atrium—coronary artery disease	0.000487	0.0245	CbGeAlD
Mefloquine—BCHE—cardiac ventricle—coronary artery disease	0.000424	0.0213	CbGeAlD
Mefloquine—CYP19A1—blood—coronary artery disease	0.000288	0.0145	CbGeAlD
Mefloquine—BCHE—heart—coronary artery disease	0.000278	0.014	CbGeAlD
Mefloquine—BCHE—cardiovascular system—coronary artery disease	0.000262	0.0132	CbGeAlD
Mefloquine—BCHE—cardiac atrium—coronary artery disease	0.000238	0.012	CbGeAlD
Mefloquine—BCHE—blood—coronary artery disease	0.000208	0.0104	CbGeAlD
Mefloquine—CYP3A4—blood—coronary artery disease	0.00014	0.00703	CbGeAlD
Mefloquine—CYP2D6—blood—coronary artery disease	0.000138	0.00691	CbGeAlD
Mefloquine—ABCB1—heart—coronary artery disease	0.000133	0.00666	CbGeAlD
Mefloquine—ABCB1—cardiovascular system—coronary artery disease	0.000125	0.00629	CbGeAlD
Mefloquine—ABCB1—blood—coronary artery disease	9.89e-05	0.00497	CbGeAlD
Mefloquine—Anxiety—Timolol—coronary artery disease	4.5e-05	0.000344	CcSEcCtD
Mefloquine—Pruritus—Olmesartan—coronary artery disease	4.49e-05	0.000344	CcSEcCtD
Mefloquine—Decreased appetite—Losartan—coronary artery disease	4.48e-05	0.000343	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.48e-05	0.000343	CcSEcCtD
Mefloquine—Abdominal pain—Captopril—coronary artery disease	4.48e-05	0.000343	CcSEcCtD
Mefloquine—Body temperature increased—Captopril—coronary artery disease	4.48e-05	0.000343	CcSEcCtD
Mefloquine—Dizziness—Simvastatin—coronary artery disease	4.47e-05	0.000342	CcSEcCtD
Mefloquine—Rash—Ezetimibe—coronary artery disease	4.47e-05	0.000342	CcSEcCtD
Mefloquine—Dermatitis—Ezetimibe—coronary artery disease	4.46e-05	0.000341	CcSEcCtD
Mefloquine—Confusional state—Ramipril—coronary artery disease	4.46e-05	0.000341	CcSEcCtD
Mefloquine—Discomfort—Timolol—coronary artery disease	4.46e-05	0.000341	CcSEcCtD
Mefloquine—Asthenia—Niacin—coronary artery disease	4.45e-05	0.00034	CcSEcCtD
Mefloquine—Fatigue—Losartan—coronary artery disease	4.45e-05	0.00034	CcSEcCtD
Mefloquine—Headache—Ezetimibe—coronary artery disease	4.44e-05	0.000339	CcSEcCtD
Mefloquine—Malaise—Lisinopril—coronary artery disease	4.43e-05	0.000339	CcSEcCtD
Mefloquine—Oedema—Ramipril—coronary artery disease	4.42e-05	0.000338	CcSEcCtD
Mefloquine—Anaphylactic shock—Ramipril—coronary artery disease	4.42e-05	0.000338	CcSEcCtD
Mefloquine—Vertigo—Lisinopril—coronary artery disease	4.42e-05	0.000338	CcSEcCtD
Mefloquine—Syncope—Lisinopril—coronary artery disease	4.41e-05	0.000337	CcSEcCtD
Mefloquine—Vomiting—Eplerenone—coronary artery disease	4.41e-05	0.000337	CcSEcCtD
Mefloquine—Feeling abnormal—Furosemide—coronary artery disease	4.41e-05	0.000337	CcSEcCtD
Mefloquine—Leukopenia—Lisinopril—coronary artery disease	4.4e-05	0.000337	CcSEcCtD
Mefloquine—Nausea—Fenofibrate—coronary artery disease	4.39e-05	0.000336	CcSEcCtD
Mefloquine—Pruritus—Niacin—coronary artery disease	4.39e-05	0.000336	CcSEcCtD
Mefloquine—Asthenia—Pravastatin—coronary artery disease	4.38e-05	0.000335	CcSEcCtD
Mefloquine—Gastrointestinal pain—Furosemide—coronary artery disease	4.37e-05	0.000335	CcSEcCtD
Mefloquine—Rash—Eplerenone—coronary artery disease	4.37e-05	0.000334	CcSEcCtD
Mefloquine—Urticaria—Perindopril—coronary artery disease	4.37e-05	0.000334	CcSEcCtD
Mefloquine—Hypersensitivity—Trandolapril—coronary artery disease	4.37e-05	0.000334	CcSEcCtD
Mefloquine—Dermatitis—Eplerenone—coronary artery disease	4.37e-05	0.000334	CcSEcCtD
Mefloquine—Diarrhoea—Valsartan—coronary artery disease	4.36e-05	0.000334	CcSEcCtD
Mefloquine—Confusional state—Timolol—coronary artery disease	4.36e-05	0.000334	CcSEcCtD
Mefloquine—Shock—Ramipril—coronary artery disease	4.35e-05	0.000333	CcSEcCtD
Mefloquine—Hypersensitivity—Enalapril—coronary artery disease	4.35e-05	0.000333	CcSEcCtD
Mefloquine—Body temperature increased—Perindopril—coronary artery disease	4.35e-05	0.000333	CcSEcCtD
Mefloquine—Abdominal pain—Perindopril—coronary artery disease	4.35e-05	0.000333	CcSEcCtD
Mefloquine—Palpitations—Lisinopril—coronary artery disease	4.34e-05	0.000332	CcSEcCtD
Mefloquine—Diarrhoea—Olmesartan—coronary artery disease	4.34e-05	0.000332	CcSEcCtD
Mefloquine—Headache—Eplerenone—coronary artery disease	4.34e-05	0.000332	CcSEcCtD
Mefloquine—Nervous system disorder—Ramipril—coronary artery disease	4.34e-05	0.000332	CcSEcCtD
Mefloquine—Thrombocytopenia—Ramipril—coronary artery disease	4.33e-05	0.000331	CcSEcCtD
Mefloquine—Anaphylactic shock—Timolol—coronary artery disease	4.32e-05	0.000331	CcSEcCtD
Mefloquine—Oedema—Timolol—coronary artery disease	4.32e-05	0.000331	CcSEcCtD
Mefloquine—Pruritus—Pravastatin—coronary artery disease	4.32e-05	0.000331	CcSEcCtD
Mefloquine—Loss of consciousness—Lisinopril—coronary artery disease	4.32e-05	0.000331	CcSEcCtD
Mefloquine—Nausea—Clopidogrel—coronary artery disease	4.32e-05	0.00033	CcSEcCtD
Mefloquine—Tachycardia—Ramipril—coronary artery disease	4.32e-05	0.00033	CcSEcCtD
Mefloquine—Skin disorder—Ramipril—coronary artery disease	4.3e-05	0.000329	CcSEcCtD
Mefloquine—Vomiting—Simvastatin—coronary artery disease	4.29e-05	0.000329	CcSEcCtD
Mefloquine—Hypersensitivity—Telmisartan—coronary artery disease	4.29e-05	0.000328	CcSEcCtD
Mefloquine—Nausea—Lovastatin—coronary artery disease	4.29e-05	0.000328	CcSEcCtD
Mefloquine—Hyperhidrosis—Ramipril—coronary artery disease	4.28e-05	0.000327	CcSEcCtD
Mefloquine—Rash—Simvastatin—coronary artery disease	4.26e-05	0.000326	CcSEcCtD
Mefloquine—Dermatitis—Simvastatin—coronary artery disease	4.25e-05	0.000326	CcSEcCtD
Mefloquine—Asthenia—Trandolapril—coronary artery disease	4.25e-05	0.000326	CcSEcCtD
Mefloquine—Shock—Timolol—coronary artery disease	4.25e-05	0.000326	CcSEcCtD
Mefloquine—Feeling abnormal—Losartan—coronary artery disease	4.25e-05	0.000325	CcSEcCtD
Mefloquine—Urticaria—Furosemide—coronary artery disease	4.25e-05	0.000325	CcSEcCtD
Mefloquine—Diarrhoea—Niacin—coronary artery disease	4.24e-05	0.000325	CcSEcCtD
Mefloquine—Nervous system disorder—Timolol—coronary artery disease	4.24e-05	0.000324	CcSEcCtD
Mefloquine—Asthenia—Enalapril—coronary artery disease	4.24e-05	0.000324	CcSEcCtD
Mefloquine—Headache—Simvastatin—coronary artery disease	4.23e-05	0.000324	CcSEcCtD
Mefloquine—Abdominal pain—Furosemide—coronary artery disease	4.23e-05	0.000323	CcSEcCtD
Mefloquine—Body temperature increased—Furosemide—coronary artery disease	4.23e-05	0.000323	CcSEcCtD
Mefloquine—Gastrointestinal pain—Losartan—coronary artery disease	4.22e-05	0.000323	CcSEcCtD
Mefloquine—Dizziness—Valsartan—coronary artery disease	4.22e-05	0.000323	CcSEcCtD
Mefloquine—Nausea—Ezetimibe—coronary artery disease	4.21e-05	0.000322	CcSEcCtD
Mefloquine—Skin disorder—Timolol—coronary artery disease	4.2e-05	0.000321	CcSEcCtD
Mefloquine—Dizziness—Olmesartan—coronary artery disease	4.2e-05	0.000321	CcSEcCtD
Mefloquine—Pruritus—Trandolapril—coronary artery disease	4.2e-05	0.000321	CcSEcCtD
Mefloquine—Chest pain—Lisinopril—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Myalgia—Lisinopril—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Arthralgia—Lisinopril—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Hyperhidrosis—Timolol—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Asthenia—Telmisartan—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Pruritus—Enalapril—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Diarrhoea—Pravastatin—coronary artery disease	4.18e-05	0.00032	CcSEcCtD
Mefloquine—Anxiety—Lisinopril—coronary artery disease	4.17e-05	0.000319	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.16e-05	0.000318	CcSEcCtD
Mefloquine—Discomfort—Lisinopril—coronary artery disease	4.13e-05	0.000316	CcSEcCtD
Mefloquine—Hypotension—Ramipril—coronary artery disease	4.13e-05	0.000316	CcSEcCtD
Mefloquine—Pruritus—Telmisartan—coronary artery disease	4.12e-05	0.000315	CcSEcCtD
Mefloquine—Nausea—Eplerenone—coronary artery disease	4.12e-05	0.000315	CcSEcCtD
Mefloquine—Dizziness—Niacin—coronary artery disease	4.1e-05	0.000314	CcSEcCtD
Mefloquine—Urticaria—Losartan—coronary artery disease	4.1e-05	0.000314	CcSEcCtD
Mefloquine—Body temperature increased—Losartan—coronary artery disease	4.08e-05	0.000312	CcSEcCtD
Mefloquine—Abdominal pain—Losartan—coronary artery disease	4.08e-05	0.000312	CcSEcCtD
Mefloquine—Asthenia—Captopril—coronary artery disease	4.06e-05	0.000311	CcSEcCtD
Mefloquine—Diarrhoea—Trandolapril—coronary artery disease	4.06e-05	0.00031	CcSEcCtD
Mefloquine—Vomiting—Valsartan—coronary artery disease	4.06e-05	0.00031	CcSEcCtD
Mefloquine—Confusional state—Lisinopril—coronary artery disease	4.05e-05	0.000309	CcSEcCtD
Mefloquine—Diarrhoea—Enalapril—coronary artery disease	4.04e-05	0.000309	CcSEcCtD
Mefloquine—Hypotension—Timolol—coronary artery disease	4.04e-05	0.000309	CcSEcCtD
Mefloquine—Dizziness—Pravastatin—coronary artery disease	4.04e-05	0.000309	CcSEcCtD
Mefloquine—Vomiting—Olmesartan—coronary artery disease	4.04e-05	0.000309	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.03e-05	0.000308	CcSEcCtD
Mefloquine—Rash—Valsartan—coronary artery disease	4.02e-05	0.000308	CcSEcCtD
Mefloquine—Dermatitis—Valsartan—coronary artery disease	4.02e-05	0.000307	CcSEcCtD
Mefloquine—Nausea—Simvastatin—coronary artery disease	4.01e-05	0.000307	CcSEcCtD
Mefloquine—Anaphylactic shock—Lisinopril—coronary artery disease	4.01e-05	0.000307	CcSEcCtD
Mefloquine—Oedema—Lisinopril—coronary artery disease	4.01e-05	0.000307	CcSEcCtD
Mefloquine—Pruritus—Captopril—coronary artery disease	4.01e-05	0.000307	CcSEcCtD
Mefloquine—Rash—Olmesartan—coronary artery disease	4e-05	0.000306	CcSEcCtD
Mefloquine—Insomnia—Ramipril—coronary artery disease	4e-05	0.000306	CcSEcCtD
Mefloquine—Dermatitis—Olmesartan—coronary artery disease	4e-05	0.000306	CcSEcCtD
Mefloquine—Headache—Valsartan—coronary artery disease	4e-05	0.000306	CcSEcCtD
Mefloquine—Diarrhoea—Telmisartan—coronary artery disease	3.99e-05	0.000305	CcSEcCtD
Mefloquine—Headache—Olmesartan—coronary artery disease	3.98e-05	0.000304	CcSEcCtD
Mefloquine—Paraesthesia—Ramipril—coronary artery disease	3.97e-05	0.000304	CcSEcCtD
Mefloquine—Shock—Lisinopril—coronary artery disease	3.95e-05	0.000302	CcSEcCtD
Mefloquine—Asthenia—Perindopril—coronary artery disease	3.95e-05	0.000302	CcSEcCtD
Mefloquine—Dyspnoea—Ramipril—coronary artery disease	3.94e-05	0.000302	CcSEcCtD
Mefloquine—Vomiting—Niacin—coronary artery disease	3.94e-05	0.000302	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Timolol—coronary artery disease	3.94e-05	0.000301	CcSEcCtD
Mefloquine—Hypersensitivity—Furosemide—coronary artery disease	3.94e-05	0.000301	CcSEcCtD
Mefloquine—Somnolence—Ramipril—coronary artery disease	3.93e-05	0.000301	CcSEcCtD
Mefloquine—Thrombocytopenia—Lisinopril—coronary artery disease	3.93e-05	0.000301	CcSEcCtD
Mefloquine—Dizziness—Trandolapril—coronary artery disease	3.92e-05	0.0003	CcSEcCtD
Mefloquine—Tachycardia—Lisinopril—coronary artery disease	3.92e-05	0.0003	CcSEcCtD
Mefloquine—Insomnia—Timolol—coronary artery disease	3.91e-05	0.000299	CcSEcCtD
Mefloquine—Rash—Niacin—coronary artery disease	3.91e-05	0.000299	CcSEcCtD
Mefloquine—Dermatitis—Niacin—coronary artery disease	3.91e-05	0.000299	CcSEcCtD
Mefloquine—Dizziness—Enalapril—coronary artery disease	3.91e-05	0.000299	CcSEcCtD
Mefloquine—Skin disorder—Lisinopril—coronary artery disease	3.9e-05	0.000298	CcSEcCtD
Mefloquine—Dyspepsia—Ramipril—coronary artery disease	3.89e-05	0.000298	CcSEcCtD
Mefloquine—Pruritus—Perindopril—coronary artery disease	3.89e-05	0.000298	CcSEcCtD
Mefloquine—Headache—Niacin—coronary artery disease	3.89e-05	0.000297	CcSEcCtD
Mefloquine—Paraesthesia—Timolol—coronary artery disease	3.88e-05	0.000297	CcSEcCtD
Mefloquine—Vomiting—Pravastatin—coronary artery disease	3.88e-05	0.000297	CcSEcCtD
Mefloquine—Hyperhidrosis—Lisinopril—coronary artery disease	3.88e-05	0.000297	CcSEcCtD
Mefloquine—Diarrhoea—Captopril—coronary artery disease	3.88e-05	0.000297	CcSEcCtD
Mefloquine—Dyspnoea—Timolol—coronary artery disease	3.86e-05	0.000295	CcSEcCtD
Mefloquine—Dizziness—Telmisartan—coronary artery disease	3.85e-05	0.000295	CcSEcCtD
Mefloquine—Rash—Pravastatin—coronary artery disease	3.85e-05	0.000295	CcSEcCtD
Mefloquine—Dermatitis—Pravastatin—coronary artery disease	3.85e-05	0.000294	CcSEcCtD
Mefloquine—Decreased appetite—Ramipril—coronary artery disease	3.85e-05	0.000294	CcSEcCtD
Mefloquine—Somnolence—Timolol—coronary artery disease	3.84e-05	0.000294	CcSEcCtD
Mefloquine—Asthenia—Furosemide—coronary artery disease	3.84e-05	0.000294	CcSEcCtD
Mefloquine—Headache—Pravastatin—coronary artery disease	3.83e-05	0.000293	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ramipril—coronary artery disease	3.82e-05	0.000292	CcSEcCtD
Mefloquine—Fatigue—Ramipril—coronary artery disease	3.81e-05	0.000292	CcSEcCtD
Mefloquine—Dyspepsia—Timolol—coronary artery disease	3.81e-05	0.000291	CcSEcCtD
Mefloquine—Hypersensitivity—Losartan—coronary artery disease	3.8e-05	0.000291	CcSEcCtD
Mefloquine—Nausea—Valsartan—coronary artery disease	3.79e-05	0.00029	CcSEcCtD
Mefloquine—Pruritus—Furosemide—coronary artery disease	3.78e-05	0.000289	CcSEcCtD
Mefloquine—Nausea—Olmesartan—coronary artery disease	3.77e-05	0.000288	CcSEcCtD
Mefloquine—Vomiting—Trandolapril—coronary artery disease	3.77e-05	0.000288	CcSEcCtD
Mefloquine—Diarrhoea—Perindopril—coronary artery disease	3.76e-05	0.000288	CcSEcCtD
Mefloquine—Decreased appetite—Timolol—coronary artery disease	3.76e-05	0.000288	CcSEcCtD
Mefloquine—Vomiting—Enalapril—coronary artery disease	3.76e-05	0.000287	CcSEcCtD
Mefloquine—Hypotension—Lisinopril—coronary artery disease	3.75e-05	0.000287	CcSEcCtD
Mefloquine—Dizziness—Captopril—coronary artery disease	3.75e-05	0.000287	CcSEcCtD
Mefloquine—Rash—Trandolapril—coronary artery disease	3.74e-05	0.000286	CcSEcCtD
Mefloquine—Dermatitis—Trandolapril—coronary artery disease	3.74e-05	0.000286	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Timolol—coronary artery disease	3.73e-05	0.000286	CcSEcCtD
Mefloquine—Fatigue—Timolol—coronary artery disease	3.73e-05	0.000285	CcSEcCtD
Mefloquine—Rash—Enalapril—coronary artery disease	3.72e-05	0.000285	CcSEcCtD
Mefloquine—Dermatitis—Enalapril—coronary artery disease	3.72e-05	0.000285	CcSEcCtD
Mefloquine—Headache—Trandolapril—coronary artery disease	3.72e-05	0.000284	CcSEcCtD
Mefloquine—Vomiting—Telmisartan—coronary artery disease	3.7e-05	0.000283	CcSEcCtD
Mefloquine—Asthenia—Losartan—coronary artery disease	3.7e-05	0.000283	CcSEcCtD
Mefloquine—Headache—Enalapril—coronary artery disease	3.7e-05	0.000283	CcSEcCtD
Mefloquine—Nausea—Niacin—coronary artery disease	3.68e-05	0.000282	CcSEcCtD
Mefloquine—Rash—Telmisartan—coronary artery disease	3.67e-05	0.000281	CcSEcCtD
Mefloquine—Dermatitis—Telmisartan—coronary artery disease	3.67e-05	0.000281	CcSEcCtD
Mefloquine—Diarrhoea—Furosemide—coronary artery disease	3.66e-05	0.00028	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.66e-05	0.00028	CcSEcCtD
Mefloquine—Pruritus—Losartan—coronary artery disease	3.65e-05	0.000279	CcSEcCtD
Mefloquine—Headache—Telmisartan—coronary artery disease	3.65e-05	0.000279	CcSEcCtD
Mefloquine—Feeling abnormal—Ramipril—coronary artery disease	3.65e-05	0.000279	CcSEcCtD
Mefloquine—Dizziness—Perindopril—coronary artery disease	3.64e-05	0.000278	CcSEcCtD
Mefloquine—Insomnia—Lisinopril—coronary artery disease	3.63e-05	0.000278	CcSEcCtD
Mefloquine—Nausea—Pravastatin—coronary artery disease	3.63e-05	0.000278	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ramipril—coronary artery disease	3.62e-05	0.000277	CcSEcCtD
Mefloquine—Paraesthesia—Lisinopril—coronary artery disease	3.6e-05	0.000276	CcSEcCtD
Mefloquine—Vomiting—Captopril—coronary artery disease	3.6e-05	0.000276	CcSEcCtD
Mefloquine—Dyspnoea—Lisinopril—coronary artery disease	3.58e-05	0.000274	CcSEcCtD
Mefloquine—Rash—Captopril—coronary artery disease	3.57e-05	0.000273	CcSEcCtD
Mefloquine—Dermatitis—Captopril—coronary artery disease	3.57e-05	0.000273	CcSEcCtD
Mefloquine—Somnolence—Lisinopril—coronary artery disease	3.57e-05	0.000273	CcSEcCtD
Mefloquine—Feeling abnormal—Timolol—coronary artery disease	3.56e-05	0.000273	CcSEcCtD
Mefloquine—Headache—Captopril—coronary artery disease	3.55e-05	0.000272	CcSEcCtD
Mefloquine—Gastrointestinal pain—Timolol—coronary artery disease	3.54e-05	0.000271	CcSEcCtD
Mefloquine—Dizziness—Furosemide—coronary artery disease	3.54e-05	0.000271	CcSEcCtD
Mefloquine—Dyspepsia—Lisinopril—coronary artery disease	3.53e-05	0.00027	CcSEcCtD
Mefloquine—Diarrhoea—Losartan—coronary artery disease	3.53e-05	0.00027	CcSEcCtD
Mefloquine—Nausea—Trandolapril—coronary artery disease	3.52e-05	0.00027	CcSEcCtD
Mefloquine—Urticaria—Ramipril—coronary artery disease	3.51e-05	0.000269	CcSEcCtD
Mefloquine—Nausea—Enalapril—coronary artery disease	3.51e-05	0.000268	CcSEcCtD
Mefloquine—Vomiting—Perindopril—coronary artery disease	3.5e-05	0.000268	CcSEcCtD
Mefloquine—Abdominal pain—Ramipril—coronary artery disease	3.5e-05	0.000268	CcSEcCtD
Mefloquine—Body temperature increased—Ramipril—coronary artery disease	3.5e-05	0.000268	CcSEcCtD
Mefloquine—Decreased appetite—Lisinopril—coronary artery disease	3.49e-05	0.000267	CcSEcCtD
Mefloquine—Rash—Perindopril—coronary artery disease	3.47e-05	0.000265	CcSEcCtD
Mefloquine—Dermatitis—Perindopril—coronary artery disease	3.46e-05	0.000265	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.46e-05	0.000265	CcSEcCtD
Mefloquine—Nausea—Telmisartan—coronary artery disease	3.46e-05	0.000265	CcSEcCtD
Mefloquine—Fatigue—Lisinopril—coronary artery disease	3.46e-05	0.000265	CcSEcCtD
Mefloquine—Headache—Perindopril—coronary artery disease	3.45e-05	0.000264	CcSEcCtD
Mefloquine—Urticaria—Timolol—coronary artery disease	3.44e-05	0.000263	CcSEcCtD
Mefloquine—Body temperature increased—Timolol—coronary artery disease	3.42e-05	0.000262	CcSEcCtD
Mefloquine—Abdominal pain—Timolol—coronary artery disease	3.42e-05	0.000262	CcSEcCtD
Mefloquine—Dizziness—Losartan—coronary artery disease	3.41e-05	0.000261	CcSEcCtD
Mefloquine—Vomiting—Furosemide—coronary artery disease	3.4e-05	0.00026	CcSEcCtD
Mefloquine—Rash—Furosemide—coronary artery disease	3.37e-05	0.000258	CcSEcCtD
Mefloquine—Dermatitis—Furosemide—coronary artery disease	3.37e-05	0.000258	CcSEcCtD
Mefloquine—Nausea—Captopril—coronary artery disease	3.36e-05	0.000257	CcSEcCtD
Mefloquine—Headache—Furosemide—coronary artery disease	3.35e-05	0.000256	CcSEcCtD
Mefloquine—Feeling abnormal—Lisinopril—coronary artery disease	3.31e-05	0.000253	CcSEcCtD
Mefloquine—Gastrointestinal pain—Lisinopril—coronary artery disease	3.28e-05	0.000251	CcSEcCtD
Mefloquine—Vomiting—Losartan—coronary artery disease	3.28e-05	0.000251	CcSEcCtD
Mefloquine—Nausea—Perindopril—coronary artery disease	3.27e-05	0.00025	CcSEcCtD
Mefloquine—Hypersensitivity—Ramipril—coronary artery disease	3.26e-05	0.000249	CcSEcCtD
Mefloquine—Rash—Losartan—coronary artery disease	3.25e-05	0.000249	CcSEcCtD
Mefloquine—Dermatitis—Losartan—coronary artery disease	3.25e-05	0.000249	CcSEcCtD
Mefloquine—Headache—Losartan—coronary artery disease	3.23e-05	0.000247	CcSEcCtD
Mefloquine—Urticaria—Lisinopril—coronary artery disease	3.19e-05	0.000244	CcSEcCtD
Mefloquine—Hypersensitivity—Timolol—coronary artery disease	3.19e-05	0.000244	CcSEcCtD
Mefloquine—Nausea—Furosemide—coronary artery disease	3.18e-05	0.000243	CcSEcCtD
Mefloquine—Asthenia—Ramipril—coronary artery disease	3.17e-05	0.000243	CcSEcCtD
Mefloquine—Abdominal pain—Lisinopril—coronary artery disease	3.17e-05	0.000243	CcSEcCtD
Mefloquine—Body temperature increased—Lisinopril—coronary artery disease	3.17e-05	0.000243	CcSEcCtD
Mefloquine—Pruritus—Ramipril—coronary artery disease	3.13e-05	0.000239	CcSEcCtD
Mefloquine—Asthenia—Timolol—coronary artery disease	3.1e-05	0.000237	CcSEcCtD
Mefloquine—Nausea—Losartan—coronary artery disease	3.06e-05	0.000234	CcSEcCtD
Mefloquine—Pruritus—Timolol—coronary artery disease	3.06e-05	0.000234	CcSEcCtD
Mefloquine—Diarrhoea—Ramipril—coronary artery disease	3.03e-05	0.000232	CcSEcCtD
Mefloquine—Diarrhoea—Timolol—coronary artery disease	2.96e-05	0.000226	CcSEcCtD
Mefloquine—Hypersensitivity—Lisinopril—coronary artery disease	2.96e-05	0.000226	CcSEcCtD
Mefloquine—Dizziness—Ramipril—coronary artery disease	2.93e-05	0.000224	CcSEcCtD
Mefloquine—Asthenia—Lisinopril—coronary artery disease	2.88e-05	0.00022	CcSEcCtD
Mefloquine—Dizziness—Timolol—coronary artery disease	2.86e-05	0.000219	CcSEcCtD
Mefloquine—Pruritus—Lisinopril—coronary artery disease	2.84e-05	0.000217	CcSEcCtD
Mefloquine—Vomiting—Ramipril—coronary artery disease	2.81e-05	0.000215	CcSEcCtD
Mefloquine—Rash—Ramipril—coronary artery disease	2.79e-05	0.000213	CcSEcCtD
Mefloquine—Dermatitis—Ramipril—coronary artery disease	2.79e-05	0.000213	CcSEcCtD
Mefloquine—Headache—Ramipril—coronary artery disease	2.77e-05	0.000212	CcSEcCtD
Mefloquine—Vomiting—Timolol—coronary artery disease	2.75e-05	0.00021	CcSEcCtD
Mefloquine—Diarrhoea—Lisinopril—coronary artery disease	2.74e-05	0.00021	CcSEcCtD
Mefloquine—Rash—Timolol—coronary artery disease	2.73e-05	0.000209	CcSEcCtD
Mefloquine—Dermatitis—Timolol—coronary artery disease	2.72e-05	0.000208	CcSEcCtD
Mefloquine—Headache—Timolol—coronary artery disease	2.71e-05	0.000207	CcSEcCtD
Mefloquine—Dizziness—Lisinopril—coronary artery disease	2.65e-05	0.000203	CcSEcCtD
Mefloquine—Nausea—Ramipril—coronary artery disease	2.63e-05	0.000201	CcSEcCtD
Mefloquine—Nausea—Timolol—coronary artery disease	2.57e-05	0.000197	CcSEcCtD
Mefloquine—Vomiting—Lisinopril—coronary artery disease	2.55e-05	0.000195	CcSEcCtD
Mefloquine—Rash—Lisinopril—coronary artery disease	2.53e-05	0.000194	CcSEcCtD
Mefloquine—Dermatitis—Lisinopril—coronary artery disease	2.53e-05	0.000193	CcSEcCtD
Mefloquine—Headache—Lisinopril—coronary artery disease	2.51e-05	0.000192	CcSEcCtD
Mefloquine—Nausea—Lisinopril—coronary artery disease	2.38e-05	0.000182	CcSEcCtD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	2.63e-06	2.67e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6ST—coronary artery disease	2.62e-06	2.66e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLCB3—coronary artery disease	2.6e-06	2.64e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKBIA—coronary artery disease	2.6e-06	2.64e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA5—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CA—coronary artery disease	2.57e-06	2.62e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DLAT—coronary artery disease	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COX5B—coronary artery disease	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.56e-06	2.6e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—coronary artery disease	2.55e-06	2.59e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—P4HB—coronary artery disease	2.53e-06	2.57e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.52e-06	2.56e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KIT—coronary artery disease	2.51e-06	2.55e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGT—coronary artery disease	2.5e-06	2.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—VCAN—coronary artery disease	2.48e-06	2.52e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	2.48e-06	2.52e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALDOA—coronary artery disease	2.46e-06	2.5e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—coronary artery disease	2.45e-06	2.48e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.44e-06	2.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.43e-06	2.47e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGT—coronary artery disease	2.42e-06	2.46e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOA1—coronary artery disease	2.42e-06	2.46e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GSK3B—coronary artery disease	2.41e-06	2.45e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—coronary artery disease	2.4e-06	2.44e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—POMC—coronary artery disease	2.39e-06	2.43e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CREB1—coronary artery disease	2.39e-06	2.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DCN—coronary artery disease	2.39e-06	2.43e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—coronary artery disease	2.37e-06	2.41e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOA1—coronary artery disease	2.35e-06	2.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—coronary artery disease	2.34e-06	2.38e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—VCAN—coronary artery disease	2.34e-06	2.37e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6R—coronary artery disease	2.33e-06	2.37e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALDH2—coronary artery disease	2.32e-06	2.36e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALDOA—coronary artery disease	2.32e-06	2.36e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—coronary artery disease	2.32e-06	2.36e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HK2—coronary artery disease	2.32e-06	2.35e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.32e-06	2.35e-05	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—coronary artery disease	2.32e-06	2.35e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.31e-06	2.35e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—coronary artery disease	2.3e-06	2.34e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—coronary artery disease	2.29e-06	2.33e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MAPK1—coronary artery disease	2.29e-06	2.33e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—POMC—coronary artery disease	2.29e-06	2.32e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—coronary artery disease	2.28e-06	2.32e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HBA1—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3C2A—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LIPC—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2C19—coronary artery disease	2.26e-06	2.3e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DCN—coronary artery disease	2.25e-06	2.29e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOC3—coronary artery disease	2.25e-06	2.29e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.25e-06	2.28e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LDLR—coronary artery disease	2.24e-06	2.27e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCND1—coronary artery disease	2.23e-06	2.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.22e-06	2.26e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC9A1—coronary artery disease	2.21e-06	2.25e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTT1—coronary artery disease	2.21e-06	2.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALDH2—coronary artery disease	2.19e-06	2.22e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.19e-06	2.22e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.19e-06	2.22e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCLC—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CETP—coronary artery disease	2.18e-06	2.22e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.18e-06	2.21e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LCAT—coronary artery disease	2.18e-06	2.21e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—coronary artery disease	2.17e-06	2.2e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SDC1—coronary artery disease	2.16e-06	2.19e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.14e-06	2.18e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA4—coronary artery disease	2.14e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LIPC—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HBA1—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	2.13e-06	2.17e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—coronary artery disease	2.13e-06	2.16e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOC3—coronary artery disease	2.12e-06	2.15e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF2—coronary artery disease	2.12e-06	2.15e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LDLR—coronary artery disease	2.11e-06	2.14e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—coronary artery disease	2.1e-06	2.14e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—POMC—coronary artery disease	2.1e-06	2.13e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—coronary artery disease	2.09e-06	2.12e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—coronary artery disease	2.08e-06	2.12e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	2.08e-06	2.12e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTT1—coronary artery disease	2.08e-06	2.12e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—coronary artery disease	2.07e-06	2.1e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCLM—coronary artery disease	2.07e-06	2.1e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.07e-06	2.1e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCLC—coronary artery disease	2.06e-06	2.09e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CETP—coronary artery disease	2.06e-06	2.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PSMA6—coronary artery disease	2.04e-06	2.07e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PSMB5—coronary artery disease	2.04e-06	2.07e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—POMC—coronary artery disease	2.04e-06	2.07e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SDC1—coronary artery disease	2.04e-06	2.07e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—JAK2—coronary artery disease	2.03e-06	2.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2e-06	2.03e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2e-06	2.03e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTGF—coronary artery disease	1.99e-06	2.03e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—coronary artery disease	1.99e-06	2.03e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.99e-06	2.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMGCR—coronary artery disease	1.98e-06	2.01e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GOT2—coronary artery disease	1.98e-06	2.01e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.97e-06	2e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—coronary artery disease	1.95e-06	1.98e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HADH—coronary artery disease	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.94e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.92e-06	1.95e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.92e-06	1.95e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—coronary artery disease	1.92e-06	1.95e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTGF—coronary artery disease	1.88e-06	1.91e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMGCR—coronary artery disease	1.86e-06	1.89e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GOT2—coronary artery disease	1.86e-06	1.89e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—coronary artery disease	1.86e-06	1.89e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—coronary artery disease	1.85e-06	1.88e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX2—coronary artery disease	1.84e-06	1.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.84e-06	1.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA2—coronary artery disease	1.84e-06	1.87e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—coronary artery disease	1.83e-06	1.86e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX4—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HK1—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLCB1—coronary artery disease	1.82e-06	1.85e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HADHA—coronary artery disease	1.8e-06	1.83e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.79e-06	1.82e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—coronary artery disease	1.79e-06	1.82e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—coronary artery disease	1.78e-06	1.81e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.78e-06	1.8e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—coronary artery disease	1.77e-06	1.8e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ABCA1—coronary artery disease	1.76e-06	1.79e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—coronary artery disease	1.76e-06	1.79e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPA—coronary artery disease	1.76e-06	1.78e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK1—coronary artery disease	1.75e-06	1.78e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCND1—coronary artery disease	1.72e-06	1.75e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.71e-06	1.74e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GOT1—coronary artery disease	1.71e-06	1.73e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GGT1—coronary artery disease	1.71e-06	1.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.7e-06	1.73e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA5—coronary artery disease	1.68e-06	1.71e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—coronary artery disease	1.68e-06	1.7e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—coronary artery disease	1.67e-06	1.7e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.66e-06	1.69e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—P4HB—coronary artery disease	1.65e-06	1.68e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—coronary artery disease	1.63e-06	1.65e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—coronary artery disease	1.62e-06	1.65e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.62e-06	1.65e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GGT1—coronary artery disease	1.61e-06	1.63e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GOT1—coronary artery disease	1.61e-06	1.63e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTP1—coronary artery disease	1.53e-06	1.56e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—VCAN—coronary artery disease	1.53e-06	1.55e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CA—coronary artery disease	1.52e-06	1.55e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.52e-06	1.54e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.52e-06	1.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—coronary artery disease	1.51e-06	1.54e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—coronary artery disease	1.5e-06	1.53e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAT—coronary artery disease	1.49e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DCN—coronary artery disease	1.47e-06	1.5e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOB—coronary artery disease	1.45e-06	1.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.44e-06	1.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.43e-06	1.45e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.43e-06	1.45e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.42e-06	1.45e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—coronary artery disease	1.41e-06	1.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAT—coronary artery disease	1.4e-06	1.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LIPC—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HBA1—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOC3—coronary artery disease	1.39e-06	1.41e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LPL—coronary artery disease	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—coronary artery disease	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LDLR—coronary artery disease	1.38e-06	1.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOB—coronary artery disease	1.36e-06	1.39e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.36e-06	1.38e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.36e-06	1.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK1—coronary artery disease	1.35e-06	1.38e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—coronary artery disease	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—coronary artery disease	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CETP—coronary artery disease	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.35e-06	1.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.33e-06	1.35e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.33e-06	1.35e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CD36—coronary artery disease	1.31e-06	1.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPL—coronary artery disease	1.3e-06	1.32e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.3e-06	1.32e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.27e-06	1.29e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.26e-06	1.28e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.26e-06	1.28e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.24e-06	1.26e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—coronary artery disease	1.24e-06	1.26e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CD36—coronary artery disease	1.24e-06	1.26e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.23e-06	1.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.22e-06	1.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.22e-06	1.24e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.22e-06	1.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGT—coronary artery disease	1.18e-06	1.2e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.17e-06	1.19e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.17e-06	1.19e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—coronary artery disease	1.16e-06	1.18e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOA1—coronary artery disease	1.14e-06	1.16e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CA—coronary artery disease	1.12e-06	1.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.12e-06	1.14e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGT—coronary artery disease	1.11e-06	1.13e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—coronary artery disease	1.09e-06	1.11e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.08e-06	1.1e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.08e-06	1.1e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.05e-06	1.07e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.05e-06	1.07e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—coronary artery disease	1.04e-06	1.06e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CA—coronary artery disease	1.03e-06	1.05e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—coronary artery disease	1.01e-06	1.03e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CA—coronary artery disease	1e-06	1.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—POMC—coronary artery disease	9.95e-07	1.01e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—coronary artery disease	9.59e-07	9.75e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—coronary artery disease	9.51e-07	9.66e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.44e-07	9.59e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—POMC—coronary artery disease	9.38e-07	9.53e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.35e-07	9.5e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.31e-07	9.46e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAT—coronary artery disease	9.18e-07	9.33e-06	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—coronary artery disease	9.16e-07	9.31e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—coronary artery disease	9.07e-07	9.22e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOB—coronary artery disease	8.92e-07	9.06e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—coronary artery disease	8.68e-07	8.82e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.67e-07	8.81e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—coronary artery disease	8.55e-07	8.69e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPL—coronary artery disease	8.51e-07	8.65e-06	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—coronary artery disease	8.42e-07	8.56e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—coronary artery disease	8.31e-07	8.44e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—coronary artery disease	8.18e-07	8.31e-06	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—coronary artery disease	8.17e-07	8.31e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CD36—coronary artery disease	8.09e-07	8.22e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.99e-07	8.12e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—coronary artery disease	7.94e-07	8.06e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.66e-07	7.79e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—coronary artery disease	7.48e-07	7.6e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGT—coronary artery disease	7.28e-07	7.4e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—coronary artery disease	7.14e-07	7.25e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA1—coronary artery disease	7.05e-07	7.17e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—coronary artery disease	6.22e-07	6.32e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—POMC—coronary artery disease	6.13e-07	6.23e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—coronary artery disease	5.59e-07	5.68e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—coronary artery disease	5.35e-07	5.43e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.89e-07	4.97e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.88e-07	4.96e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.6e-07	4.68e-06	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—coronary artery disease	3.99e-07	4.05e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—coronary artery disease	3.76e-07	3.82e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.01e-07	3.06e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.46e-07	2.5e-06	CbGpPWpGaD
